Observational studyFrontiers in immunology2020

Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.

Zhibo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.